Basem M. William

OhioHealth — United States

Medicine · Health Sciences

30h-index4.4kcitations242works0.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(89), CAR-T cell therapy research(74), Hematopoietic Stem Cell Transplantation(46), T-cell and Retrovirus Studies(37), Cutaneous lymphoproliferative disorders research(36)

Publications241 total

Suppl Fig 2 from Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma
2025Open Access
Suppl Fig 3 from Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma
2025Open Access
Supplementary Data1 from Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma
2025Open Access
Suppl Fig 1 from Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma
2025Open Access
A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis
Blood Advances·2025· 1 citedOpen Access
Whole-genome sequencing (WGS)-based circulating tumor DNA (ctDNA) monitoring in diffuse-large B-cell lymphoma (DLBCL)
Blood·2025
Real-world evaluation of ctdna for risk stratification across the spectrum of both aggressive and indolent lymphomas
Blood·2025Open Access
Curcumin and resveratrol sensitizes TP53 mutant acute myeloid leukemia (AML) cell lines to venetoclax-induced apoptosis
Blood·2025Open Access
Teclistamab and Talquetamab in Relapse/Refractory Multiple Myeloma (RRMM) Patients with Severe Renal Insufficiency: Case Series
Clinical Lymphoma Myeloma & Leukemia·2025
0696 Impact of race on survival of patients with primary cutaneous CD30+ T-cell lymphoproliferative disorders: A longitudinal analysis of the SEER database (1988-2011)
Journal of Investigative Dermatology·2025
Review for "Five‐Year Follow‐Up of Patients With Relapsed and Refractory Classic Hodgkin Lymphoma Treated With Low‐Dose Nivolumab (40 mg): A Matched Cohort Study With Standard‐Dose Therapy"
2025
Narrowing of the Racial Disparities Gap in Survival of Patients With Mycosis Fungoides: A Longitudinal Analysis of the SEER Database
Clinical Lymphoma Myeloma & Leukemia·2025
Effect of Diazepam on Thyroid Function Hormone and Associated Histological Markers
PHARMACOLOGY MEDICAL REPORTS ORTHOPEDIC AND ILLNESS DETAILS (COMORBID)·2025Open Access
Enhancing Primary School Completion Rates in Kagadi District, Uganda: A Participatory Action Research Approach
International Journal of Scientific and Research Publications·2025
Tolerability of Teclistamab and Talquetamab in Relapse/Refractory Multiple Myeloma (RRMM) Patients with Severe Renal Insufficiency: Case Series
Transplantation and Cellular Therapy·2025
Feasibility of Longitudinal Circulating Tumor DNA (ctDNA) Assessment in Patients with Peripheral and Cutaneous T-Cell Lymphomas
Blood·2024
Final Results of a Phase 2, Single Arm Trial Evaluating Letermovir for Cytomegalovirus Prophylaxis in Patients with Hematological Malignancies Treated with Alemtuzumab
Blood·2024
Final Results of a Phase II Study of Brentuximab Vedotin and Lenalidomide in Relapsed and Refractory T-Cell Lymphomas
Blood·2024· 2 citedOpen Access
Supplementary Data1 from Targeting the Inducible T-cell Costimulator (ICOS) in patients with Relapsed/Refractory T-Follicular Helper Phenotype Peripheral T-Cell and Angioimmunoblastic T-Cell Lymphoma
2024Open Access
Suppl Fig 3 from Targeting the Inducible T-cell Costimulator (ICOS) in patients with Relapsed/Refractory T-Follicular Helper Phenotype Peripheral T-Cell and Angioimmunoblastic T-Cell Lymphoma
2024Open Access
page 1 of 13Next →

Frequent Co-authors

Pierluigi Porcu(10), Youn H. Kim(9), Ahmad Halwani(8), Hillard M. Lazarus(7), Jonathan E. Brammer(7), Samantha Jaglowski(7), Bradley M. Haverkos(6), Mohamed A. Kharfan‐Dabaja(6), Ayman Saad(6), Baldeep Wirk(6), Sam Penza(6), Theresa Pacheco(5), Christiane Querfeld(5), Kwang Woo Ahn(5), Hannah Choe(5), Siddhartha Ganguly(5), Richard F. Olsson(5), Joan Guitart(5), Jamés O. Armitage(5), Taiga Nishihori(5)